Conestoga Capital Advisors’s Kadant KAI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$47.2M Sell
150,265
-59,684
-28% -$18.6M 1.03% 30
2026
Q1
$61.4M Sell
209,949
-6,255
-3% -$2.01M 1.23% 30
2025
Q4
$61.6M Buy
216,204
+47,506
+28% +$13.5M 1.04% 35
2025
Q3
$50.2M Sell
168,698
-53,353
-24% -$17.4M 0.81% 44
2025
Q2
$70.5M Buy
222,051
+842
+0.4% +$264K 1.04% 38
2025
Q1
$74.5M Buy
221,209
+109,439
+98% +$39.8M 1.12% 34
2024
Q4
$38.6M Buy
+111,770
New +$40.5M 0.51% 52

Other funds holding KAI

Conestoga Capital Advisors's KAI Position: Q2 2026 in Review

Conestoga Capital Advisors reduced its Kadant (KAI) stake by 28% in Q2 2026, selling an estimated $18.6M and leaving 150,265 shares worth $47.2M. The position accounts for 1.03% of the portfolio, ranked #30.

Conestoga Capital Advisors first reported a position in KAI in Q4 2024 and has held it in 7 quarters since. The position peaked at $74.5M in Q1 2025. 326 funds tracked by Wall St. Rank hold KAI as of Q2 2026.

  • Conestoga Capital Advisors held 150,265 shares of Kadant worth $47.2M as of Q2 2026.
  • Conestoga Capital Advisors sold 59,684 Kadant shares in Q2 2026, an estimated $18.6M.
  • Kadant made up 1.03% of Conestoga Capital Advisors's portfolio in Q2 2026, its #30 holding.
  • Conestoga Capital Advisors first reported a position in Kadant in Q4 2024 and has held it in 7 quarters since.
  • Conestoga Capital Advisors's Kadant position peaked at $74.5M in Q1 2025.
  • 326 funds tracked by Wall St. Rank held Kadant as of Q2 2026.

Based on Conestoga Capital Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.